Trial Profile
Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Oct 2015
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Lewy body disease
- Focus Therapeutic Use
- 14 Oct 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 16 Oct 2014 Planned End Date changed from 1 Aug 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.
- 16 Oct 2014 Planned primary completion date changed from 1 Aug 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.